BlackRock Institutional Trust’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$35.8M Buy
1,306,520
+199,401
+18% +$8.01M 0.01% 1551
2016
Q3
$68M Buy
1,107,119
+58,501
+6% +$1.77M 0.01% 1104
2016
Q2
$20M Sell
1,048,618
-20,295
-2% -$376K ﹤0.01% 1849
2016
Q1
$20.9M Buy
1,068,913
+25,799
+2% +$451K ﹤0.01% 1804
2015
Q4
$40.2M Buy
1,043,114
+106,965
+11% +$3.47M 0.01% 1395
2015
Q3
$30.1M Sell
936,149
-172,167
-16% -$5.84M 0.01% 1553
2015
Q2
$33.7M Sell
1,108,316
-60,583
-5% -$1.24M 0.01% 1556
2015
Q1
$15.5M Buy
1,168,899
+295
+0% +$3.93K ﹤0.01% 2108
2014
Q4
$16.9M Buy
1,168,604
+91,835
+9% +$1.56M ﹤0.01% 2013
2014
Q3
$22.7M Buy
1,076,769
+9,553
+0.9% +$216K ﹤0.01% 1793
2014
Q2
$31.8M Buy
1,067,216
+31,706
+3% +$1M 0.01% 1635
2014
Q1
$24.9M Buy
1,035,510
+40,667
+4% +$1.04M ﹤0.01% 1814
2013
Q4
$20.3M Buy
994,843
+91,009
+10% +$2.7M ﹤0.01% 1932
2013
Q3
$42.7M Buy
903,834
+48,706
+6% +$1.88M 0.01% 1301
2013
Q2
$32.5M Buy
+855,128
New +$30.6M 0.01% 1441

Other funds holding SRPT